Dr. Ginocchio is the first voting member of PACCARB from the in vitro diagnostics industry.
As the prevalence of AKI increases, so does the mounting personal and financial costs of this condition. The condition is associated with a tenfold increase in hospital mortality rates and a higher rate of chronic kidney disease among post-op patients.
Paul Ehrlich was born in 1854 in the Polish town of Strzelin, which, at the time of his birth, fell within the Kingdom of Prussia. This Nobel Prize-winning physician made enormous contributions in the fields of chemotherapy, immunology, microbiology and oncology.